Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study
Javier García Corbacho, Alberto Indacochea, Azucena E. González Navarro, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 6, pp. 1709-1723
Open Access | Times Cited: 14

Showing 14 citing articles:

CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial
Francesco Schettini, Michela Palleschi, Francesca Mannozzi, et al.
The Oncologist (2024) Vol. 29, Iss. 5, pp. e622-e634
Open Access | Times Cited: 8
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study
Javier García Corbacho, Alberto Indacochea, Iván Victoria, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer
Shaukat Ali, Mahnoor Arshad, Muhammad Summer, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Practice Variation in Perioperative Dexamethasone Use and Outcomes in Brain Metastasis Resection
David Wasilewski, Tommaso Araceli, Artem Rafaelian, et al.
JAMA Network Open (2025) Vol. 8, Iss. 4, pp. e254689-e254689
Open Access
Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications
Francesco Schettini, Federica Gattazzo, Sabrina Nucera, et al.
Cancer Treatment Reviews (2024) Vol. 130, pp. 102816-102816
Open Access | Times Cited: 3
Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study
Francesco Schettini, Alessandra Fontana, Federica Gattazzo, et al.
European Journal of Cancer (2023) Vol. 191, pp. 112948-112948
Open Access | Times Cited: 7
Prognosis stratification of cancer patients treated with immune checkpoint inhibitors through lung immune prognostic index: a meta-analysis and systematic review
Yusheng Guo, Yao Pan, Jiayu Wan, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Next-Generation Sequencing-Based Evaluation of the Actionable Mutational Landscape in Solid Tumors: the “MOZART” Prospective Observational Study
Francesco Schettini, Marianna Sirico, Marco Loddo, et al.
Research Square (Research Square) (2024)
Open Access
Pan‐cancer evaluation of tumor‐infiltrating lymphocytes and programmed cell death protein ligand‐1 in metastatic biopsies and matched primary tumors
Zakhia El Beaino, Célia Dupain, Grégoire Marret, et al.
The Journal of Pathology (2024) Vol. 264, Iss. 2, pp. 186-196
Open Access
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the “MOZART” prospective observational study
Francesco Schettini, Marianna Sirico, Marco Loddo, et al.
The Oncologist (2024)
Open Access
Targeting immunometabolism to improve cancer therapies
Darby J. Ballard, Liqing Wang, Jugal Kishore Das, et al.
Elsevier eBooks (2024), pp. 95-116
Closed Access
Unexpected Durable Complete Response With Anti–PD-L1 Blockade in Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report With Host and Tumor Biomarker Analysis
David Pesántez, Alberto Indacochea, Laura Angelats, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 1
Impact of Perioperative Dexamethasone in the Context of Neurosurgical Brain Metastasis Resection
David Wasilewski, Jan Bukatz, Ricarda Peukert, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Editorial: Diagnostic, prognostic and predictive factors of response in the era of precision oncology in breast cancer
Diletta Favero, Daniele Generali, Francesco Schettini
Frontiers in Oncology (2023) Vol. 13
Open Access
Page 1

Scroll to top